Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam D Post

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 15, 2011
Surgical risk score predicts suboptimal debulking or a major perioperative complication in patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancerCaitlin Stashwick, Miriam D Post, Jaime S Arruda, et al.
Molecular Cancer Therapeutics|May 19, 2022
Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian CarcinomaBrooke E Sanders, Tomomi M Yamamoto, Alexandra McMellen, et al.
Histopathology|December 10, 2024
Serous-like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumoursGregor Krings, Eliah R Shamir, Marick Laé, et al.
Breast Cancer Research and Treatment|February 23, 2011
Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpointMelanie M Badtke, Purevsuren Jambal, Wendy W Dye, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 10, 2014
Outcomes of women with atypical glandular cells on preoperative cytology and endometrial cancerMichael S Guy, Georgina Cheng, Miriam D Post, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|November 14, 2014
Lymphovascular space invasion in robotic surgery for endometrial cancerMark R Hopkins, Abby M Richmond, Georgina Cheng, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2015
Cytokeratin 5-Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian CancerBradley R Corr, Jessica Finlay-Schultz, Rachel B Rosen, et al.
Gynecologic Oncology|February 16, 2012
Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancerLubna Qamar, Erin Deitsch, Aaron N Patrick, et al.
Endocrine-Related Cancer|October 24, 2012
Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasionKristen K Rumer, Miriam D Post, Rhea S Larivee, et al.
Cancer Research|October 21, 2010
Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasisMonique A Spillman, Nicole G Manning, Wendy W Dye, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 15, 2011
Surgical risk score predicts suboptimal debulking or a major perioperative complication in patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancerCaitlin Stashwick, Miriam D Post, Jaime S Arruda, et al.
Molecular Cancer Therapeutics|May 19, 2022
Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian CarcinomaBrooke E Sanders, Tomomi M Yamamoto, Alexandra McMellen, et al.
Histopathology|December 10, 2024
Serous-like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumoursGregor Krings, Eliah R Shamir, Marick Laé, et al.
Breast Cancer Research and Treatment|February 23, 2011
Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpointMelanie M Badtke, Purevsuren Jambal, Wendy W Dye, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 10, 2014
Outcomes of women with atypical glandular cells on preoperative cytology and endometrial cancerMichael S Guy, Georgina Cheng, Miriam D Post, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|November 14, 2014
Lymphovascular space invasion in robotic surgery for endometrial cancerMark R Hopkins, Abby M Richmond, Georgina Cheng, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2015
Cytokeratin 5-Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian CancerBradley R Corr, Jessica Finlay-Schultz, Rachel B Rosen, et al.
Gynecologic Oncology|February 16, 2012
Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancerLubna Qamar, Erin Deitsch, Aaron N Patrick, et al.
Endocrine-Related Cancer|October 24, 2012
Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasionKristen K Rumer, Miriam D Post, Rhea S Larivee, et al.
Cancer Research|October 21, 2010
Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasisMonique A Spillman, Nicole G Manning, Wendy W Dye, et al.
Pageof 8